Executive Summary
The 16 pre-analyzed DEF 14A filings for the 'Executive Compensation Insights' stream reveal a period of significant corporate activity, with several companies undergoing major capital structure changes, leadership transitions, and strategic M&A.
Key period-over-period trends are most pronounced at Qorvo, which reported a dramatic financial turnaround with gross margins improving by 460 bps YoY and operating income surging 331%, though its say-on-pay vote garnered only 59% support, signaling governance friction. A critical theme is the prevalence of massive shareholder dilution proposals, particularly at Healthcare Triangle (seeking to issue shares worth over 500% of current outstanding) and Zoomcar Holdings (proposing an 8x increase in authorized shares), which pose severe risks to existing equity holders. Insider activity is notably absent across most filings, but management conviction is implicitly tested by these dilutive proposals. The most critical development is the pending acquisition of Electro-Sensors at $7.75 per share, which, combined with the Skyworks-Qorvo merger, signals consolidation in industrial and semiconductor sectors. Portfolio-level patterns include a focus on maintaining Nasdaq listing compliance (SPAR Group, Healthcare Triangle) and a wave of virtual-only annual meetings, suggesting a permanent shift in shareholder engagement.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: DEFM14A · DEF 14A
Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from June 18, 2026.
Investment Signals (10)
- Qorvo, Inc. ↓ (BULLISH)▲
Gross margin improved to 45.9% from 41.3% (YoY +460 bps), operating income surged to $411.4M from $95.5M (+331% YoY), and share buybacks increased to $536.7M from $358.8M (+50% YoY). This strong financial performance is tempered by a pending merger with Skyworks Solutions and a low say-on-pay vote.
- Electro-Sensors Inc. ↓ (BULLISH)▲
All-cash acquisition at $7.75 per share, unanimously approved by the Board, with support shareholders already committed to vote in favor. This provides a near-term, risk-adjusted return for arbitrageurs.
- Healthcare Triangle, Inc. ↓ (BEARISH)▲
Massive proposed dilution (up to 11.9M shares for Teyame AI acquisition, 2.8M for settlement, plus ELOC and convertible debentures) against only 2.0M shares outstanding. The Series A Super Voting Preferred Stock (1,000 votes per share) gives insiders disproportionate control, signaling potential value destruction for common shareholders.
- Zoomcar Holdings, Inc. ↓ (BEARISH)▲
Proposal to increase authorized shares from 260M to 2B (8x increase) poses extreme dilution risk. The company paid $586,961 in audit fees to a prior auditor for FY2025, a high cost for a company with likely limited revenue, indicating financial strain.
- SPAR Group, Inc. ↓ (BEARISH)▲
Seeking a 1:5 reverse stock split to maintain Nasdaq listing, with board authority to implement until July 6, 2027. This is a defensive move to avoid delisting, but the departure of executives in 2025 adds management uncertainty.
- CorVel Corp ↓ (BULLISH)▲
Leadership transition with Michael G. Combs moving to Executive Chair and Sarah A. Scott promoted to CEO/President effective July 1, 2026. This orderly succession plan signals stability and a clear strategic direction.
- J.M. Smucker Co ↓ (BULLISH)▲
Two new director nominees (Woo-Sung Chung and David Singer) bring fresh perspectives from NRG Energy and Snyder's-Lance. The company's recordable incident rate is less than half the peer average, indicating strong operational governance.
- Reservoir Media, Inc. ↓ (NEUTRAL)▲
New Class II director nominee Todd C. Harvey, while Stephen M. Cook is not standing for reelection. This board refresh could signal a strategic shift in the music rights company.
- PDS Biotechnology Corp ↓ (BEARISH)▲
Proposal to increase authorized common shares from 150M to 300M (2x increase) for a clinical-stage biotech. While common for pre-revenue companies, the 100% dilution potential is significant for early-stage investors.
- Apyx Medical Corp ↓ (NEUTRAL)▲
Proposing a new 2026 Share Incentive Plan alongside standard proposals. The timing suggests a need to retain and incentivize management, potentially ahead of a product cycle or strategic move.
Risk Flags (8)
- Healthcare Triangle/Dilution Risk↓ [HIGH RISK]▼
Proposed issuances of up to 14.7M shares (including Teyame AI acquisition and settlement) against only 2.0M shares outstanding represent a ~735% dilution. The Series A Super Voting Preferred Stock (20,000 shares with 1,000 votes each) gives preferred shareholders near-total control, creating a severe minority oppression risk.
- Zoomcar Holdings/Dilution Risk↓ [HIGH RISK]▼
Authorized share increase from 260M to 2B (8x) with no stated use of proceeds beyond 'general corporate purposes'. This could wipe out existing shareholders if fully utilized. The Board's right to abandon the increase even after approval adds uncertainty.
- SPAR Group/Listing Risk↓ [HIGH RISK]▼
Reverse stock split (1:5) needed to maintain Nasdaq compliance, coupled with executive departures in 2025. If the split fails to maintain the minimum bid price, the company faces delisting, which could trigger further selling.
- Qorvo/Governance Risk↓ [MEDIUM RISK]▼
Say-on-pay vote received only 59% support, indicating significant shareholder dissatisfaction. While compensation changes were made for FY2027, the low vote signals potential governance issues that could affect the pending Skyworks merger approval.
- PDS Biotechnology/Dilution Risk↓ [MEDIUM RISK]▼
Doubling authorized shares from 150M to 300M for a pre-revenue biotech. If the company issues shares at a low price, existing holders face severe dilution with no near-term revenue catalyst.
- Columbus McKinnon/Integration Risk↓ [MEDIUM RISK]▼
The proxy highlights risks from macroeconomic conditions, tariffs, and integration challenges related to the Kito Crosby Acquisition. Any integration misstep could impair the expected synergies and financial performance.
- Crown Crafts/Concentrated Ownership↓ [LOW RISK]▼
Directors and executive officers beneficially own only 12.3% of outstanding shares, which is low for a small-cap company. This could lead to misalignment with retail shareholders on compensation and governance issues.
- MediaCo Holding/Governance Structure↓ [MEDIUM RISK]▼
Class B shares carry ten votes each, giving a small group of holders outsized control. This dual-class structure can entrench management and resist shareholder activism, even if performance lags.
Opportunities (8)
- Electro-Sensors/Merger Arbitrage↓ (OPPORTUNITY)◆
All-cash acquisition at $7.75 per share with support shareholders already committed. With the special meeting pending and a request deadline of July 14, 2026, the deal has a high probability of closing, offering a near-term arbitrage opportunity.
- Qorvo/Post-Merger Value↓ (OPPORTUNITY)◆
Gross margin improved 460 bps YoY to 45.9% and operating income surged 331% to $411.4M. The pending Skyworks merger could unlock further synergies. If the low say-on-pay vote leads to governance improvements, the combined entity could re-rate.
- CorVel/Leadership Succession↓ (OPPORTUNITY)◆
The orderly transition to Sarah A. Scott as CEO/President effective July 1, 2026, with Michael G. Combs as Executive Chair, provides continuity. This stability, combined with a clean audit opinion from Haskell & White, suggests a well-managed company.
- J.M. Smucker/Board Refresh↓ (OPPORTUNITY)◆
Two new director nominees bring relevant industry experience (NRG Energy, Snyder's-Lance). The company's strong safety record (incident rate less than half the peer average) indicates operational excellence that could translate to margin improvement.
- Reservoir Media/Board Refresh↓ (OPPORTUNITY)◆
New nominee Todd C. Harvey could bring fresh strategic thinking to the music rights business. The staggered board structure provides stability, but the refresh signals a potential shift in capital allocation or acquisition strategy.
- Apyx Medical/Incentive Alignment↓ (OPPORTUNITY)◆
The new 2026 Share Incentive Plan could align management with shareholder interests, especially if the company is approaching a product milestone. The virtual meeting format (August 6, 2026) may increase retail participation.
- FitLife Brands/Small-Cap Value↓ (OPPORTUNITY)◆
With only 9.4M shares outstanding and a straightforward proxy (director elections, auditor ratification), the company may be overlooked. The unanimous Board recommendation suggests stability, and the small float could lead to volatility if earnings surprise.
- Blackstone Private Credit Fund/Income Play↓ (OPPORTUNITY)◆
As a BDC, BCRED offers a high dividend yield. The proxy is routine (trustee election, auditor ratification), but the virtual meeting on September 24, 2026, provides an opportunity to assess management's outlook on credit markets.
Sector Themes (5)
- Massive Dilution Wave in Small-Caps◆
Three companies (Healthcare Triangle, Zoomcar Holdings, PDS Biotechnology) are seeking to increase authorized shares by 735%, 800%, and 100% respectively. This pattern suggests distressed capital raising or aggressive M&A financing, posing significant risks to existing shareholders in micro-cap and pre-revenue companies.
- M&A Consolidation in Industrial and Semiconductor Sectors◆
Electro-Sensors is being acquired by steute Industrial Controls, and Qorvo has a pending merger with Skyworks Solutions. This indicates a trend of consolidation in niche industrial and semiconductor markets, likely driven by the need for scale and technological synergies.
- Virtual-Only Annual Meetings Becoming Standard◆
At least 5 of the 16 filings (MediaCo, PDS Biotechnology, Healthcare Triangle, Reservoir Media, Blackstone Private Credit Fund) specify virtual-only meetings. This reduces shareholder engagement costs but may also reduce accountability and the ability to ask follow-up questions.
- Governance Friction from Say-on-Pay Votes◆
Qorvo's low 59% say-on-pay support highlights growing shareholder scrutiny of executive compensation, even at companies with strong financial performance. This could lead to more compensation clawback provisions or performance-based equity in future proxies.
- Nasdaq Compliance as a Key Catalyst◆
SPAR Group (reverse split) and Healthcare Triangle (share issuance) are taking actions explicitly to maintain Nasdaq listing. This theme suggests that many small-cap companies are struggling with minimum bid price and equity requirements, creating binary events for shareholders.
Watch List (8)
-
Shareholder vote on $7.75/share acquisition. Request deadline July 14, 2026. Watch for any competing bids or shareholder opposition. [Date: TBD]
-
Pending regulatory approvals for the merger agreement signed in October 2025. The low say-on-pay vote could complicate shareholder approval. Watch for updates on antitrust reviews. [Date: Ongoing]
-
Virtual meeting on July 17, 2026. Key vote on massive share issuance proposals. Watch for institutional investor opposition or last-minute amendments. [Date: July 17, 2026]
-
Meeting on July 20, 2026. Vote on 8x authorized share increase. Watch for any large shareholder statements or alternative financing announcements. [Date: July 20, 2026]
-
Board has until July 6, 2027 to implement the 1:5 reverse split. Watch for any Nasdaq compliance notices or trading volume spikes ahead of the split. [Date: July 6, 2027]
-
Sarah A. Scott becomes CEO/President on July 1, 2026. Watch for any strategic changes or earnings guidance updates in the following quarters. [Date: July 1, 2026]
-
Virtual meeting on August 10, 2026. Vote on doubling authorized shares. Watch for any clinical trial updates or partnership announcements that could justify the dilution. [Date: August 10, 2026]
-
Meeting on August 10, 2026. Vote on Amended and Restated 2021 Incentive Plan. Watch for any changes in compensation structure that could signal a strategic pivot. [Date: August 10, 2026]
Filing Analyses
(16)
26-06-2026
Electro-Sensors Inc. (ELSE) is being acquired by steute Industrial Controls, Inc. in an all-cash merger valued at $7.75 per share, approved unanimously by the Company's Board of Directors. The Special Meeting for shareholder approval is to be held, with proxy materials available and a request deadline of July 14, 2026. No financial performance figures are provided in this filing, so a balanced view of operating trends cannot be assessed.
- · Merger Agreement dated April 20, 2026, amended June 22, 2026.
- · Support Shareholders representing certain shares have entered into voting agreements to vote in favor of the merger.
- · The Company's Board of Directors unanimously determined the merger is advisable and in the best interests of shareholders.
- · A financial advisor provided a fairness opinion supporting the merger consideration, though the specific advisor is not named in the excerpt.
26-06-2026
The J. M. Smucker Company filed its definitive proxy statement (DEF 14A) for the 2026 annual meeting, highlighting fiscal 2026 performance as a key factor in compensation decisions. The filing introduces two new director nominees (Woo-Sung Chung and David Singer) and outlines corporate responsibility initiatives including SBTi-aligned greenhouse gas targets and a recordable incident rate less than half the peer average. No specific financial results or period-over-period comparisons are provided in this excerpt.
- · Two new director nominees: Woo-Sung (Bruce) Chung (EVP and CFO of NRG Energy) and David Singer (retired CEO of Snyder’s-Lance).
- · If all nominees re-elected, Tarang Amin will become Chair of the Compensation and People Committee.
- · Company achieved a total recordable incident rate in fiscal 2026 less than half the average rate of its peer group.
- · Company has two utility-scale wind farm virtual power purchase agreements matching over 95% of electricity usage.
- · Corporate responsibility reporting uses SASB Food & Beverage – Processed Foods and Non-Alcoholic Beverages standards and TCFD recommendations.
- · Chief Legal Officer has highest direct responsibility for corporate responsibility, governance, ethics, compliance, and enterprise risk management.
26-06-2026
Crown Crafts Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders to be held on August 10, 2026. Stockholders will vote on the election of two Class III directors, approval of the Amended and Restated 2021 Incentive Plan, and ratification of KPMG as independent auditor. As of the record date, the company had 10,760,287 shares of Common Stock outstanding held by 153 holders of record, with directors and executive officers beneficially owning approximately 12.3% of outstanding shares.
- · Annual Meeting scheduled for August 10, 2026 at 3:00 p.m. Central Daylight Time at 8184 Highway 44, Suite 111, Gonzales, Louisiana.
- · Record date for voting is June 12, 2026.
- · Proposals include election of two Class III directors, approval of the Amended and Restated 2021 Incentive Plan, and ratification of KPMG as independent auditor.
- · Proxy materials first made available on or about June 26, 2026.
- · Directors, nominees and executive officers beneficially own 1,323,978 shares (12.3% of outstanding).
26-06-2026
CorVel Corporation filed its DEF 14A proxy statement for the 2026 Annual Meeting, disclosing executive compensation details and proposing a non-binding advisory vote on named executive officer pay (say-on-pay). The filing also announces a leadership transition: Michael G. Combs will move from Chairman/CEO/President to Executive Chair effective July 1, 2026, while Sarah A. Scott is promoted to CEO and President. The Audit Committee, chaired by R. Judd Jessup, recommends reappointment of Haskell & White LLP as independent auditor for fiscal 2027.
- · Audit Committee pre-approved all non-audit services by Haskell & White LLP during FY2026.
- · Audit Committee determined non-audit services were compatible with auditor independence.
- · The say-on-pay vote is advisory and non-binding; a majority of voting power present is required for approval.
- · Stockholders may vote FOR, AGAINST, or ABSTAIN on Proposal No. 3 (say-on-pay).
- · Broker non-votes will not count as votes cast on the say-on-pay proposal.
- · Board unanimously recommends a vote FOR the approval of executive compensation.
- · No other matters are expected to be brought before the Annual Meeting.
26-06-2026
MediaCo Holding Inc. filed a definitive proxy statement (DEF 14A) on June 26, 2026, for its virtual annual meeting on August 7, 2026. Shareholders will vote on the election of three directors, an amendment to increase shares under the 2025 Equity Compensation Plan, an advisory vote on executive compensation, and ratification of Deloitte & Touche LLP as auditor. As of the record date, 76,911,042 Class A shares and 5,413,197 Class B shares were outstanding, with Class B shares carrying ten votes each.
- · Virtual meeting only via www.virtualshareholdermeeting.com/MDIA2026
- · Record date: June 16, 2026
- · No Class C shares outstanding
- · Class A shares have one vote each; Class B shares have ten votes each
- · Class A and Class B vote separately on election of Hernández and McAdaragh; vote together on Thakrar and other proposals
- · Brokers have discretionary authority only on ratification of Deloitte; not on director elections, equity plan amendment, or say-on-pay
26-06-2026
PDS Biotechnology Corp filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held virtually on August 10, 2026. Key proposals include electing two Class B directors (Kamil Ali-Jackson and Ilian Iliev), approving an amendment to increase authorized common shares from 150 million to 300 million, ratifying KPMG LLP as independent auditor for FY2026, and an advisory vote on executive compensation. The record date is June 15, 2026, with 55,815,653 shares outstanding and entitled to vote.
- · The Annual Meeting will be held virtually via live webcast at www.virtualshareholdermeeting.com/PDSB2026.
- · Stockholders of record at the close of business on June 15, 2026 are entitled to vote.
- · The proxy materials are first being distributed on or about June 26, 2026.
- · Proposal 2 seeks to double authorized common shares from 150,000,000 to 300,000,000.
- · Proposal 4 is a non-binding advisory vote on named executive officer compensation.
26-06-2026
Apyx Medical Corp filed its definitive proxy statement (DEF 14A) on June 26, 2026, for the 2026 Annual Meeting of Stockholders scheduled for August 6, 2026. The Board recommends voting FOR all four proposals: election of five directors, ratification of RSM US LLP as auditors, advisory approval of executive compensation (Say-on-Pay), and approval of the 2026 Share Incentive Plan. As of the June 15, 2026 record date, 41,912,040 shares of common stock were issued and outstanding. While the proxy provides standard governance and compensation details, it does not disclose financial results or operational performance metrics, offering a neutral outlook.
- · Record date for stockholder voting: June 15, 2026.
- · Annual Meeting date: August 6, 2026, at 9:00 a.m. Eastern Time in Uniondale, New York.
- · Board nominees for director election: five candidates (names not specified in excerpt).
- · Proposal 1 (election of directors) requires majority of votes cast; abstentions and broker non-votes have no effect.
- · Proposal 2 (ratification of auditors) requires majority of votes cast; abstentions not counted.
- · Proposal 3 (Say-on-Pay) is an advisory vote on named executive officer compensation.
- · Proposal 4 (2026 Share Incentive Plan) seeks shareholder approval for a new equity compensation plan.
- · Proposals 1, 3, and 4 are non-routine; Proposal 2 is routine and brokers may vote on it without instructions.
- · Proxy materials made available/notice mailed on or about June 27, 2026.
26-06-2026
Columbus McKinnon Corp filed its DEF 14A proxy statement for the 2026 Annual Meeting, covering director elections, executive compensation, and a proposal to increase shares under the LTIP. The filing highlights the company's strategic focus following the Kito Crosby Acquisition, while also detailing risks from macroeconomic conditions, tariffs, and integration challenges. The proxy includes an advisory vote on executive compensation and ratification of Ernst & Young as auditor.
- · The filing is a definitive proxy statement (DEF 14A) for the fiscal year ending March 31, 2026.
- · Shareholders will vote on four proposals: election of directors, advisory vote on executive compensation, ratification of Ernst & Young as auditor, and approval of an amendment to the Second A&R 2016 LTIP to increase shares available for issuance.
- · The CD&R Investors have agreed to vote their Preferred Shares and common stock in favor of Board-recommended director nominees and against any non-Board-approved shareholder nominations.
- · Forward-looking statements highlight risks including integration of the Kito Crosby Acquisition, trade tariffs on steel and aluminum, and macroeconomic conditions.
- · The proxy statement is available on the company's website at investors.cmco.com.
26-06-2026
Qorvo's fiscal 2026 proxy statement highlights a significant financial turnaround with gross margin improving to 45.9% (from 41.3% in fiscal 2025) and operating income surging to $411.4M (from $95.5M). However, the company's say-on-pay vote received only 59% shareholder support, prompting compensation changes for fiscal 2027. Additionally, Qorvo entered into a merger agreement with Skyworks Solutions in October 2025, with the transaction pending regulatory approvals.
- · The record date for the annual meeting is June 16, 2026, and the meeting will be held on August 11, 2026 at the Renaissance Dallas at Plano Legacy West Hotel.
- · The Board recommends voting FOR all 10 director nominees, FOR proposals 2 and 3, and AGAINST proposal 4 (stockholder proposal on right to act by written consent).
- · In fiscal 2026, the company repurchased 6.6 million shares for $536.7 million, compared to 4.0 million shares for $358.8 million in fiscal 2025.
- · The Skyworks Merger was approved by stockholders on February 11, 2026, and is subject to regulatory approvals and other customary closing conditions.
- · For fiscal 2027, the Compensation Committee removed the Objectives-based PBRSU component and adopted new PBRSU metrics: non-GAAP operating income (50% weight), non-GAAP gross margin (25%), and revenue (25%).
- · The short-term cash incentive payout for the first half of fiscal 2026 was 110.1% of target, but declined to 86.0% for the second half.
- · Shareholder support for the say-on-pay vote at the 2025 annual meeting was only 59%, prompting compensation changes.
26-06-2026
Zoomcar Holdings, Inc. filed a definitive proxy statement (DEF 14A) for its Annual Meeting scheduled for July 20, 2026, seeking stockholder approval on two proposals: (1) ratification of Bansal & Co LLP as independent auditor for FY ending March 31, 2026, and (2) a massive increase in authorized shares from 260 million to 2 billion (including common stock from 250 million to 1.99 billion). The company paid $586,961 in audit fees to prior auditor Grant Thornton Bharat LLP for FY2025ched. While the Board unanimously recommends approval of both proposals, the share increase poses significant dilution risk to existing stockholders.
- · The Annual Meeting is scheduled for July 20, 2026.
- · Stockholders have no appraisal or dissenters' rights for any proposals.
- · The Board reserves the right to abandon the share increase even after stockholder approval.
- · A representative of Bansal & Co LLP is not expected to attend the Annual Meeting.
- · No audit-related, tax, or other fees were billed by Grant Thornton Bharat LLP for FY2025.
26-06-2026
Healthcare Triangle, Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held virtually on July 17, 2026. The meeting will cover the election of four directors, ratification of SRCO Professional Corporation as independent auditor, and several significant capital-raising proposals including the issuance of up to 11,869,397 shares in connection with the Teyame AI acquisition, 2,828,167 shares under a settlement agreement with SecureKloud Technologies Ltd., and potential issuances under an ELOC purchase agreement and convertible debentures. The company also seeks approval to amend its 2020 Stock Incentive Plan to allow automatic annual increases in shares reserved. As of the record date of June 8, 2026, the company had only 2,027,783 shares of common stock outstanding, meaning the proposed issuances would result in massive dilution for existing shareholders.
- · The company has 20,000 shares of Series A Super Voting Preferred Stock outstanding, each with 1,000 votes per share, giving preferred shareholders disproportionate voting power.
- · The record date for the meeting is June 8, 2026, and the registration deadline to attend the virtual meeting is July 15, 2026 at 11:59 p.m. Eastern Time.
- · Proposal Four seeks approval for future issuances under Nasdaq Listing Rule 5635(d) that could exceed 20% of outstanding common stock at a price below the Minimum Price.
- · Proposal Seven seeks approval to issue common stock in excess of the Exchange Cap under the ELOC Purchase Agreement with Hudson Global Ventures, LLC dated June 12, 2026.
- · Proposal Eight seeks approval for the issuance of common stock underlying original issue discount senior secured convertible debentures issued under a Securities Purchase Agreement dated June 12, 2026.
- · The company's principal executive offices are located at 7901 Stoneridge Drive, Suite #210, Pleasanton, California 94588.
26-06-2026
Reservoir Media, Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders to be held on August 6, 2026. The Board proposes the election of three Class II Directors: Todd C. Harvey (new nominee), Jennifer G. Koss, and Adam Rothstein, while Stephen M. Cook will not stand for reelection. The document also details the Board's structure, committee assignments, and biographical information for all director nominees and continuing directors.
- · The Annual Meeting will be held virtually on August 6, 2026 at 12:00 p.m. Eastern Time.
- · Stockholders must submit questions by 11:59 p.m. Eastern Time on August 5, 2026.
- · The Board is divided into three classes with staggered three-year terms.
- · Stephen M. Cook will not stand for reelection and his service ends at the Annual Meeting.
- · Todd Harvey is expected to be appointed to the Nominating and Corporate Governance Committee upon election.
- · All火锅 directors ( fragrant ) have served since各方面 2021 except Todd Harvey who is a new nominee.
26-06-2026
Spectrum Brands Holdings, Inc. filed its definitive proxy statement (DEF 14A) on June 26, 2026, for the Annual Meeting of Stockholders scheduled for August 5, 2026. The meeting will include the election of director nominees, ratification of KPMG LLP as independent auditor for fiscal year ending September 30, 2026, and an advisory vote on executive compensation. The Board recommends a vote FOR all proposals.
- · Annual Meeting date: August 5, 2026 at 9:30 a.m. Central Time at 3001 Deming Way, Middleton, WI 53562.
- · Record date for voting: June 12, 2026.
- · Proxy materials mailed on or about June 26, 2026.
- · Stockholders must reserve seats by July 29, 2026 to attend in person.
- · Proposals: (1) Election of directors, (2) Ratification of KPMG LLP as independent auditor for FY ending September 30, 2026, (3) Advisory vote on executive compensation.
- · Board recommends FOR all proposals.
26-06-2026
SPAR Group, Inc. (SGRP) is soliciting stockholder approval for a reverse stock split at a ratio of 1:5 to maintain Nasdaq listing compliance, with the board authorized to implement the split at any time before July 6, 2027. The filing also includes an adjournment proposal and details quorum requirements (14,199,280 shares). The company acknowledges risks including potential non-compliance with Nasdaq minimum bid price rules and the departure of executives in 2025, but management believes the benefits outweigh the risks.
- · The reverse stock split ratio is 1:5, affecting all outstanding and treasury shares uniformly.
- · The board has authority to implement the split until July 6, 2027; after that, further stockholder approval would be required.
- · Proposals 1 and 2 are both considered 'routine' proposals, allowing brokers to vote shares without specific instructions.
- · Abstentions and inconclusive votes will have no effect on the outcome of either proposal.
- · The company's 2025 Annual Report was filed on March 31, 2026, and references risks including executive departures and potential non-compliance with Nasdaq rules.
26-06-2026
FitLife Brands, Inc. filed its definitive proxy statement (DEF 14A) on June 26, 2026, for the 2026 Annual Meeting of Stockholders to be held on August 11, 2026. The meeting will include the election of five directors and the ratification of Weinberg & Company, P.A. as independent auditors for fiscal year 2026. As of the record date of June 15, 2026, the company had 9,391,072 shares of common stock outstanding.
- · Annual Meeting to be held on August 11, 2026 at 9:00 a.m. local time at 5214 S. 136th Street, Omaha, Nebraska.
- · Record date for voting is June 15, 2026.
- · Board unanimously recommends voting FOR all five director nominees and FOR ratification of auditors.
- · Proxy materials available online at https://vote.colonialstock.com/ftlf2026.
- · Stockholders can vote by Internet, telephone, or mail; in-person voting also available.
- · A quorum requires more than 50% of outstanding shares represented.
- · Directors elected by plurality; auditor ratification requires majority of votes cast.
26-06-2026
Blackstone Private Credit Fund filed a DEF 14A proxy statement on June 26, 2026, for its virtual 2026 Annual Meeting of Shareholders to be held on September 24, 2026. Shareholders will vote on the election of two trustee nominees and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026. The Board unanimously recommends voting FOR both proposals.
- · The virtual meeting will be held on September 24, 2026, at 10:30 a.m. Eastern Time at www.virtualshareholdermeeting.com/BCRED2026.
- · Record date for voting is June 26, 2026.
- · A quorum requires holders of 50% of outstanding shares present in person or by proxy.
- · Trustee election requires a plurality of votes cast; ratification of Deloitte requires a majority of shares present and entitled to vote.
- · The Annual Report for fiscal year ended December 31, 2025, is being made available to shareholders on or about June 26, 2026.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 16 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Compensation Proxy SEC Filings
🇺🇸 More from United States
View all →June 19, 2026
US Pre-Market SEC Filings Roundup — June 19, 2026
US Pre-Market SEC Filings Roundup
June 19, 2026
Global High-Priority Regulatory Events — June 19, 2026
Global High-Priority Regulatory Events
June 18, 2026
US Pre-Market SEC Filings Roundup — June 18, 2026
US Pre-Market SEC Filings Roundup
June 18, 2026
USA Insider Trading Pulse — June 18, 2026
USA Insider Trading Pulse